Buddy Creech
-
November 3, 2022
Event to spotlight VUMC’s COVID-19 research efforts
The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall. -
September 7, 2022
VUMC study will evaluate alternative strategies for administering mpox vaccine
Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms. -
June 16, 2022
VUMC research aids approval of COVID-19 vaccine for young children
The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday. -
May 12, 2022
VUMC-led study finds Moderna COVID vaccine safe and effective for children
-
March 30, 2022
Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.
“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction." -
February 24, 2022
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C). -
February 3, 2022
Study finds shorter treatment better for young children with outpatient pneumonia
A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.